Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future (vol 9, e001926, 2021)

被引：0
|
作者：
Alzeibak, R.
Mishchenko, T. A.
Shilyagina, N. Y.
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷 / 10期
关键词：
D O I：
10.1136/jitc-2020-001926corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PD-L1 testing in non-small cell lung cancer: past, present, and future (vol 53, pg 199, 2019)
    Kim, Hyojin
    Chung, Jin-Haeng
    [J]. JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2020, 54 (02) : 196 - 196
  • [42] Complete metabolic response in patients with advanced non-small cell lung cancer with prolonged response to immune checkpoint inhibitor therapy (vol 9, e002262, 2021)
    Ferdinandus, J.
    Metzenmacher, M.
    Kessler, L.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [43] Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer (vol 9, e002886, 2021)
    Zubiri, Leyre
    Molina, Gabriel E.
    Mooradian, Meghan J.
    Cohen, Justine
    Durbin, Sienna M.
    Petrillo, Laura
    Boland, Genevieve M.
    Juric, Dejan
    Dougan, Michael
    Thomas, Molly F.
    Faje, Alex T.
    Rengarajan, Michelle
    Guidon, Amanda C.
    Chen, Steven T.
    Okin, Daniel
    Medoff, Benjamin D.
    Nasrallah, Mazen
    Kohler, Minna J.
    Schoenfeld, Sara R.
    Karp-Leaf, Rebecca S.
    Sise, Meghan E.
    Neilan, Tomas G.
    Zlotoff, Daniel A.
    Farmer, Jocelyn R.
    Bardia, Aditya
    Sullivan, Ryan J.
    Blum, Steven M.
    Semenov, Yevgeniy R.
    Villani, Alexandra-Chloe
    Reynolds, Kerry L.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [44] RETRACTION: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells (Retraction of Vol 8, art no E60975, 2013)
    Riganti, C.
    Castella, B.
    Kopecka, J.
    Campia, I
    Coscia, M.
    Pescarmona, G.
    [J]. PLOS ONE, 2020, 15 (12):
  • [45] AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake (vol 9, e92948, 2014)
    Rashmi, R.
    DeSelm, C.
    Helms, C.
    Bowcock, A.
    Rogers, B. E.
    Rader, Janet L.
    [J]. PLOS ONE, 2014, 9 (09):
  • [46] AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake (vol 9, e92948, 2014)
    Rader, Janet S.
    [J]. PLOS ONE, 2016, 11 (05):
  • [47] Photodynamic therapy induces human esophageal carcinoma cell pyroptosis by targeting the PKM2/caspase-8/caspase-3/GSDME axis (vol 520, pg 143, 2021)
    Li, Lisha
    Song, Dongfeng
    Qi, Ling
    Jiang, Mingxia
    Wu, Yiming
    Gan, Junqing
    Cao, Kui
    Li, Yanjing
    Bai, Yuxian
    Zheng, Tongsen
    [J]. CANCER LETTERS, 2022, 525 : 203 - 205
  • [48] Phthalocyanine-mediated photodynamic therapy induces cell death and a G0/G1 cell cycle arrest in cervical cancer cells (vol 339, pg 569, 2006)
    Haywood-Small, SL
    Vernon, DI
    Griffiths, J
    Schofield, J
    Brown, SB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (02) : 673 - 673
  • [49] Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets (vol 15, 133, 2022)
    Qin, Rui
    You, Feng-Ming
    Zhao, Qian
    Xie, Xin
    Peng, Cheng
    Zhan, Gu
    Han, Bo
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [50] RETRACTION: Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy (Retraction of Vol 9, 10.3389/FCELL.2021.686453, 2021)
    Hassanzadeh, A.
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
12345